Summerville D A, Packard A B, Bartynski B, Lim K S, Chervu L R, Treves S T
J Nucl Med. 1987 May;28(5):907-9.
The renal clearance of the technetium-99m complex of para[(biscarboxylmethyl)-aminomethylcarboxyamino]hippuric acid ([99mTc]PAHIDA), has been previously studied in rodents and falls between that of [99mTc]DTPA (diethylenetriaminepentaacetic acid) and iodine-131 (131I) orthoiodohippuran (OIH). To investigate the effect of species variation, the plasma clearance of [99mTc]PAHIDA was investigated in dogs. The plasma disappearance of the renal agent approached that of [99mTc]DTPA and was significantly less than that of OIH. Despite the structural similarities of the PAHIDA ligand and aminohippurate, the [99mTc]PAHIDA complex undergoes little, if any, tubular secretion in the canine kidney.
对氨基[(双羧甲基)-氨甲基羧基氨基]马尿酸([99mTc]PAHIDA)的锝-99m复合物的肾清除率,此前已在啮齿动物中进行过研究,其清除率介于[99mTc]二乙三胺五乙酸(DTPA)和碘-131(131I)邻碘马尿酸(OIH)之间。为研究物种差异的影响,对犬类进行了[99mTc]PAHIDA血浆清除率的研究。肾脏药物的血浆消失情况接近[99mTc]DTPA,且显著低于OIH。尽管PAHIDA配体和氨基马尿酸盐在结构上相似,但[99mTc]PAHIDA复合物在犬肾中极少(如果有的话)发生肾小管分泌。